About this trial
This study will look at how eating peanuts every day might affect participants weight, how healthy their diet is, and how they feel when eating. Investigators want to see if adding peanuts to meals for 12 weeks helps participants feel fuller, have more energy, and improve body composition. The study will include adults who have been taking GLP-1 medicines like semaglutide or tirzepatide for at least three months. Investigators also want to see if eating peanuts improves overall diet quality and health markers like tiredness and certain levels in blood.
Eligibility criteria
Qualifiers
Individuals with a BMI ≥30 kg/m2 or with a BMI ≥27 kg/m2 with at least one weight-related comorbidity who have been using semaglutide or tirzepatide for a clinical indication or at least 6 months
Disqualifiers
No use or contraindication to use of a GLP-1 RA
Known allergy to nuts
Pregnant or breastfeeding
Incarcerated
Trial design
Treatments tested in this trial
- Peanuts
- Dual-energy X-ray absorptiometry (DEXA) scans
Treatment groups
Locations
1Map coordinates are unavailable for these locations. Locations are shown below instead.
Sponsors and collaborators
Ian J. Neeland, MD
Lead sponsor
University Hospitals Cleveland Medical Center
Sponsor institution